Explorer

Govt Fast Tracks Approvals For Foreign-Made COVID Jabs To Expand Vaccination Coverage

Centre is fast tracking Emergency Approvals for foreign-produced COVID19 vaccines that have been granted Emergency Use Authorization (EUA) in other countries to expand the basket of vaccines for domestic use and hasten the pace and coverage of vaccination. 

The Government of India on Tuesday announced that the Centre has fast tracked Emergency Approvals for foreign-produced COVID-19 vaccines that have been granted Emergency Use Authorization (EUA) in other countries to expand the basket of vaccines for domestic use and hasten the pace and coverage of vaccination. 

ALSO READ | 'Cancel CBSE 2021 Board Exams': CM Arvind Kejriwal Appeals To Centre As Delhi Records 13,500 New COVID Cases

The Ministry of Health and Family Welfare in an official release said that Vaccination is one of the critical pillars of COVID control and management strategy adopted by the Centre. At present, National Regulator Drugs Controller General of India has approved Emergency Use Authorization (EUA) to two vaccines i.e. Covaxin by Bharat Biotech International Limited (BBIL) and Covishield by Serum Institute of India (SII).

Now, the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) after a comprehensive meeting on April 11, recommended that vaccines for COVID-19, which have been developed & are being manufactured in foreign countries and which have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO(Emergency Use Listing) may be granted emergency use approval in India.

The ministry clarified that the first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunization programme within the country.

ALSO READ | BJP Under Fire After Gujarat Leader Offers 'Free Jabs' Of Limited Remdesivir In Surat; Congress, AAP Demand Strict Action

After due consideration, the government of India has accepted the recommendation of NEGVAC with the aim to facilitate quicker access to such foreign vaccines by India. The health ministry said that the move would encourage imports including import of bulk drug material, optimal utilisation of domestic fill and finish capacity etc., which will in turn provide a fillip to vaccine manufacturing capacity and total vaccine availability for domestic.

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headline

PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
Actor Govinda Joins Eknath Shinde's Shiv Sena, Likely To Contest From Mumbai North West
Actor Govinda Joins Eknath Shinde's Shiv Sena, Likely To Contest From Mumbai North West
Sanjiv Bhatt Gets 20 Years In Jail Day After Conviction In 1996 Drug Seizure Case
Sanjiv Bhatt Gets 20 Years In Jail Day After Conviction In 1996 Drug Seizure Case
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Advertisement
for smartphones
and tablets

Videos

Bihar Lok Sabha Polls 2024: ABP Exclusive With Papu Yadav, MP No Longer Contesting From PurniaVarun Gandhi Pens Emotional Letter To Pilibhit After Being Denied, Says 'Mai Aapka Hu Aur Rahunga'Delhi Excise Policy Case: With CM Arvind Kejriwal's Arrest, Who Will Run The State | Watch ReportLok Sabha Elections 2024: 'BJP Just Wants To Break The Aam Aadmi Party' says Saurabh Bhardwaj

Photogallery

Embed widget